NEA Management Company as of June 30, 2013
Portfolio Holdings for NEA Management Company
NEA Management Company holds 31 positions in its portfolio as reported in the June 2013 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Groupon | 33.4 | $748M | 88M | 8.55 | |
Tesaro | 14.4 | $323M | 9.9M | 32.74 | |
Epizyme | 7.6 | $170M | 6.0M | 28.13 | |
Clovis Oncology | 6.8 | $153M | 2.3M | 66.98 | |
Xoom | 5.2 | $116M | 5.1M | 22.92 | |
Fusion-io | 4.5 | $100M | 7.0M | 14.24 | |
Omthera Pharmaceutica-ls | 3.5 | $78M | 5.8M | 13.30 | |
Millennial Media | 3.2 | $72M | 8.2M | 8.71 | |
Supernus Pharmaceuticals (SUPN) | 3.1 | $69M | 11M | 6.43 | |
Hyperion Therapeutics | 2.8 | $64M | 2.9M | 22.00 | |
Channeladvisor | 1.9 | $44M | 2.8M | 15.73 | |
Boingo Wireless | 1.8 | $40M | 6.4M | 6.21 | |
Audience | 1.7 | $38M | 2.9M | 13.21 | |
Sunesis Pharmaceuticals | 1.3 | $29M | 5.6M | 5.19 | |
Lexicon Pharmaceuticals | 1.1 | $25M | 12M | 2.17 | |
Nektar Therapeutics (NKTR) | 0.9 | $21M | 1.8M | 11.55 | |
Targacept | 0.9 | $20M | 4.6M | 4.27 | |
Cadence Pharmaceuticals | 0.6 | $14M | 2.1M | 6.82 | |
Linkedin Corp | 0.6 | $14M | 77k | 178.30 | |
Amicus Therapeutics (FOLD) | 0.6 | $13M | 5.7M | 2.33 | |
Glu Mobile | 0.6 | $13M | 5.9M | 2.21 | |
InterMune | 0.6 | $13M | 1.3M | 9.62 | |
Alimera Sciences | 0.6 | $13M | 2.7M | 4.88 | |
Rigel Pharmaceuticals | 0.5 | $11M | 3.2M | 3.34 | |
Exelixis (EXEL) | 0.5 | $10M | 2.2M | 4.54 | |
Semiconductor Manufacturing Int'l | 0.4 | $8.3M | 2.3M | 3.65 | |
Solta Medical | 0.3 | $6.5M | 2.9M | 2.28 | |
Transcept Pharmaceuticals | 0.3 | $6.3M | 2.1M | 3.02 | |
ArQule | 0.3 | $5.8M | 2.5M | 2.32 | |
Zhone Technologies | 0.2 | $3.8M | 4.8M | 0.80 | |
NeuroMetrix | 0.0 | $115k | 57k | 2.01 |